Results 1 to 10 of about 1,165 (74)

Xanthone-1,2,4-triazine and Acridone-1,2,4-triazine Conjugates: Synthesis and Anticancer Activity

open access: yesPharmaceuticals, 2023
A total of 21 novel xanthone and acridone derivatives were synthesized using the reactions of 1,2,4-triazine derivatives with 1-hydroxy-3-methoxy-10-methylacridone, 1,3-dimethoxy-, and 1,3-dihydroxanthone, followed by optional dihydrotiazine ring ...
Sougata Santra   +11 more
doaj   +1 more source

Role of deregulated microRNAs in breast cancer progression using FFPE tissue. [PDF]

open access: yesPLoS ONE, 2013
MicroRNAs (miRNAs) contribute to cancer initiation and progression by silencing the expression of their target genes, causing either mRNA molecule degradation or translational inhibition.
Liang Chen   +12 more
doaj   +1 more source

High CD90 (THY-1) expression positively correlates with cell transformation and worse prognosis in basal-like breast cancer tumors. [PDF]

open access: yesPLoS ONE, 2018
Breast cancer is the most prevalent cancer among women, with the basal-like triple negative (TNBC) being the most agressive one, displaying the poorest prognosis within the ductal carcinoma subtype.
Aline Ramos Maia Lobba   +8 more
doaj   +1 more source

β-Arrestin2 regulates lysophosphatidic acid-induced human breast tumor cell migration and invasion via Rap1 and IQGAP1. [PDF]

open access: yesPLoS ONE, 2013
β-Arrestins play critical roles in chemotaxis and cytoskeletal reorganization downstream of several receptor types, including G protein-coupled receptors (GPCRs), which are targets for greater than 50% of all pharmaceuticals.
Mistre Alemayehu   +7 more
doaj   +1 more source

Non-redundant roles of the phosphoinositide phosphatases PTEN and PIPP in PI3K/AKT signaling in breast cancer. [PDF]

open access: yesCommun Biol
Ooms LM   +11 more
europepmc   +1 more source

HSF2 drives breast cancer progression by acting as a stage-specific switch between proliferation and invasion. [PDF]

open access: yesSci Adv
Pessa JC   +11 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy